Predicta Biosciences
Biotechnology company utilizing AI and multi-omics to develop personalized diagnostics and treatment options, enabling precision medicine approaches for complex diseases.
Website
https://www.predictabio.comLocation
Boston, Massachusetts, USA
Founded
2020
Investors
1
Categories
ai, multiomics, personalized-medicine, diagnostics, biotech
Notes
Predicta Biosciences is a biotechnology company that utilizes artificial intelligence and multi-omics data analysis to develop personalized diagnostics and treatment recommendations. The company's platform integrates genomic, proteomic, metabolomic, and other omics data to provide comprehensive patient profiles.
By combining multi-omics analysis with AI/ML algorithms, Predicta enables precision medicine approaches that can match patients with optimal treatments.
Team
- Leadership team with expertise in AI, genomics, and precision medicine
Additional Research Findings
- Founded in 2020 in Boston, Massachusetts
- AI/ML platform for multi-omics analysis
- Focus on personalized diagnostics
- Integrates multiple omics data types
- Applications in precision medicine
- Enabling treatment optimization through patient profiling
- Part of growing AI-enabled diagnostics space
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Illumina Ventures | San Francisco, California, USA | biotech-focused | seedseries-a+1 | 32 |